Logo

LSBC Q3 Revenues Inch Over $1M Mark, Losses Narrow

Oct 22, 2003

NEW YORK, Oct. 22 (GenomeWeb News) – Large Scale Biology reported revenues of $1.2 million for the third quarter, compared to $0.7 million in the same period last year.

The Vacaville, Calif., company had a net loss of $4.3 million for the quarter, compared to $6.8 million for the third quarter of 2002.

LSBC's R&D expenses decreased to $2.8 million, from $4.5 million in the year-ago quarter.

At the end of the third quarter, the company had $11.3 million in cash and marketable securities.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.